Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

2 ways Baxter’s CEO is transforming the company

June 8, 2017 By Chris Newmarker

Baxter CEO Jose Joe AlmeidaFrom improved corporate culture to less bureaucracy to internal innovation, CEO José Almeida has been priming Baxter for success since taking over a year and a half ago.

The former CEO of Covidien, who led the company to it $50 billion merger with Medtronic in January 2015, jumped at the opportunity to lead Baxter. The company “started with a great mission, products essential to health care,” Almeida said last week at Healthegy’s Medtech Conference in Minneapolis.

The company among other things sells lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.

“What a chance to take this portfolio,” Almeida said. “What an opportunity financially as well, when I look at the balance sheet, the great leverage opportunity. And also coming to a company that had in the past a culture of innovation that may have lost its way. So why not bring what I know, what I’ve learned, from so many good people in my career to Baxter.”

Besides, Almeida was ready for new challenges after the Medtronic-Covidien deal: “How many rounds of tennis can you play every day?”

Since Almeida officially stepped into Baxter’s CEO spot in January 2016, the company’s stock has risen more than a third in value, to about $60 per share. During its most recent quarter, sales and profits beat analysts’ expectations. Baxter is now in the position to shop for other companies to acquire, Almeida said.

Here are 2 changes Almeida brought to Baxter since he took over:

1. Reducing bureaucracy and improving the workplace

Almeida recalls that Baxter had culturally developed a bad habit of people saying, “Let’s do more analysis.”

“I used to take 2 pieces of paper and rub them against each other. I said, ‘This is the sound of our company working. This paper going back and forth,'” Almeida said.

Almeida has worked to reduce layers in the organization and encourage employees to make decisions on their own. Overall, he wants to make sure Baxter is a great place to work because a company can’t accomplish its strategic goals if its employees are miserable on the job.

Almeida admits that improving corporate culture is a never-ending process.

“Culture is like having a garden. You don’t plant it, you don’t take care, … pretty quickly it goes away from you. It will revert back. So it is like Nitinol,” Almeida said.

2. Boosting innovation

Almeida said accelerating innovation can start with better portfolio management.

“So the first thing we did was to understand where the money was being spent, and unfortunately, it was being spent in areas which had very little effect on the growth of the company, and even clinically they were very difficult to produce results., as well as technically to produce results. So the first thing was to reallocate money,” Almeida said.

In the process, innovations were discovered sitting on the shelves. For example, one in-house innovation was a system to generate sterile solutions at home, on-demand, for home peritoneal dialysis. The system could be a game-changer for at-home dialysis because patients presently need enough space in their home for a month’s supply of solution, up to 40 boxes. Some simply don’t have the space. Baxter in May received clarification from FDA on the regulatory pathway for the on-demand solution technology, which is expected to have its first clinical trial in 2018 and regulatory submission in 2019.

Baxter employees are also becoming more aware of what is being developed elsewhere at universities and hospitals. Baxter is also revamping its venture capital business.

“We did not have any contacts in Israel. You think about. If you were a med tech and you don’t have a foot in Israel, you’re missing a big part of innovation. So we are inking a couple of agreements with universities in Israel. We just did a [Mayo Clinic] deal, and we’re going to [do] more in terms of strategic portfolio management in venture capital, then financial returns,” Almeida said.

“You gotta make sure that you have eyes and ears everywhere, because I can guarantee there’s always somebody else as smart or smarter than we are doing something much more focused 24/7, and none of us are doing 24/7 anything singularly.”

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

You may also like:

  • 3D printing medtech startups Ultimaker 3
    3D printing can give your medtech startup a competitive edge
  • medical device manufacturing U.S.
    Why U.S. first may be the new medical device development…
  • Boston Scientific
    Here is Boston Scientific’s plan to win in medtech
  • medical device value design healthcare medtech
    4 steps to deeper medical device design insights

Related Articles Read More >

A photo of former FDA official Bakul Patel
Google Health hires FDA’s chief digital health officer
FDA
FDA moves forward with Voluntary Improvement Program to bolster medical device quality
Medtronic Hugo robot-assisted surgery system
The road to a robot: Medtronic’s development process for its Hugo RAS system
iRhythm stays silent on federal grand jury subpoenas

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech